WOCKPHARMA

WOCKHARDT

Small Cap BSE: 532300 NSE: WOCKPHARMA
₹228.15
-7.85 (-3.33%)
As on 07 December, 2022 | 06:04

Wockhardt Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in WOCKHARDT

Start SIP

Wockhardt Share Price

Wockhardt Share Returns

  • Over 1 Month -4.62%
  • Over 3 Month -10.7%
  • Over 6 Month -12.94%
  • Over 1 Year -46.74%

Wockhardt Key Statistics

P/E Ratio -6.3
PEG Ratio 0
Market Cap Cr 3,287
Price to Book Ratio 0.8
EPS -9.7
Dividend 0
Relative Strength Index 38.86
Money Flow Index 45.66
MACD Signal -0.81
Average True Range 7.37

Wockhardt Investment Rating

  • Master Rating:
  • Wockhardt has an operating revenue of Rs. 2,782.89 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of -13% needs improvement, ROE of -6% is poor and needs improvement. The company has a reasonable debt to equity of 9%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 3 which is a POOR score indicating inconsistency in earnings, a RS Rating of 9 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has some relative strength and buyer demand but we want to see further fundamental performance to qualify as a growth stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Wockhardt Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 258241474309310279262
Operating Expenses Qtr Cr 247236288294301262284
Operating Profit Qtr Cr 11518615917-22
Depreciation Qtr Cr 47474343434252
Interest Qtr Cr 58617879605545
Tax Qtr Cr -40-1747-37-26-29-66
Net Profit Qtr Cr -75-3740-67-64-49-47

Wockhardt Technicals

EMA & SMA

Current Price
228.15
-7.85 (-3.33%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 237.42
  • 50 Day
  • 239.63
  • 100 Day
  • 245.66
  • 200 Day
  • 274.14
  • 20 Day
  • 236.14
  • 50 Day
  • 239.84
  • 100 Day
  • 239.76
  • 200 Day
  • 258.59

Wockhardt Resistance and Support

PIVOT
₹238.69
Resistance
First Resistance 242.32
Second Resistance 248.64
Third Resistance 252.27
RSI 38.86
MFI 45.66
MACD Single Line -0.81
MACD -0.88
Support
First Resistance 232.37
Second Resistance 228.74
Third Resistance 222.42

Wockhardt Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,264,877 124,364,396 54.91
Week 1,314,652 63,011,290 47.93
1 Month 711,559 31,721,315 44.58
6 Month 921,296 33,747,079 36.63

Wockhardt Result Highlights

Wockhardt Synopsis

NSE-Medical-Generic Drugs

Wockhardt Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1372.00 Cr. and Equity Capital is Rs. 72.00 Cr. for the Year ended 31/03/2022. Wockhardt Ltd. is a Public Limited Listed company incorporated on 08/07/1999 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1999PLC120720 and registration number is 120720.
Market Cap 3,287
Sales 1,282
Shares in Float 5.19
No of funds 94
Yield
Book Value 1.49
U/D Vol ratio 0.9
LTDebt / Equity 7
Alpha -0.22
Beta 0.98

Wockhardt

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 63.83%65.75%67.13%
Mutual Funds 0.03%0.03%0.03%
Insurance Companies
Foreign Portfolio Investors 2.98%2.81%2.88%
Financial Institutions/ Banks
Individual Investors 27.42%25.97%24.56%
Others 5.74%5.44%5.4%

Wockhardt Management

Name Designation
Dr. Habil Khorakiwala Founder Chairman
Dr. Murtaza Khorakiwala Managing Director
Dr. Huzaifa Khorakiwala Executive Director
Ms. Zahabiya Khorakiwala Non Executive Director
Mr. Aman Mehta Independent Director
Mr. D S Brar Independent Director
Dr. Sanjaya Baru Independent Director
Mrs. Tasneem Mehta Independent Director
Mr. Vinesh Kumar Jairath Independent Director
Mr. Akhilesh Gupta Independent Director
Mrs. Rima Marphatia Nominee Director

Wockhardt Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Wockhardt Corporate Action

Date Purpose Remarks
2022-11-04 Quarterly Results
2022-08-12 Quarterly Results
2022-05-30 Audited Results
2022-03-03 Rights issue
2022-01-27 Quarterly Results

Wockhardt MF Shareholding

Name Amount(cr)
Motilal Oswal Nifty 500 Fund Regular Growth 368
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 367
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 309
SBI Nifty Smallcap 250 Index Fund Regular Growth 103
ICICI Prudential S&P BSE 500 ETF 69

Wockhardt FAQs

What is Share Price of Wockhardt ?

Wockhardt share price is ₹228 As on 07 December, 2022 | 05:50

What is the Market Cap of Wockhardt ?

The Market Cap of Wockhardt is ₹3286.7 Cr As on 07 December, 2022 | 05:50

What is the P/E ratio of Wockhardt ?

The P/E ratio of Wockhardt is -6.3 As on 07 December, 2022 | 05:50

What is the PB ratio of Wockhardt ?

The PB ratio of Wockhardt is 0.8 As on 07 December, 2022 | 05:50

Q2FY23